1 of 24

Single-Cell RNA-Seq Analysis of Microglia in Alzheimer’s Disease

Ifthekar Hussain�Computational Analysis Task

2 of 24

Study Objectives

  • Identify microglial gene expression changes across disease groups:
    • NND → nAD → iAD
  • Compare:
    • NND (healthy) vs nAD (Alzheimer’s)
    • nAD vs iAD (immunized Alzheimer’s)
  • Identify key microglial genes that are significantly up- or down-regulated
  • Perform GO Biological Process enrichment to link genes to pathways and functions

3 of 24

Dataset & Study Design

  • Dataset:
    • GSE263034, scRNA-seq
    • 25 samples
    • Donors: NND = 6, nAD = 6, iAD= 13
  • Analysis Workflow

4 of 24

Quality Control ( Before Filtering)

  • Dataset contains variable cell quality
  • Outliers with:
    • Very low features
    • Very low UMIs
    • High mitochondrial percentage
  • Applied QC thresholds to remove low-quality

5 of 24

.

6 of 24

Quality Control(After Filtering)

  • Removed cells with extremely low RNA content
    • nCount_RNA < (median − 3 × MAD) per-sample threshold
    • nFeature_RNA < (median − 2 × MAD) per-sample threshold
  • Removed high-mitochondrial cells
    • percent.mt > 20%
  • Removed doublets
    • Detected using scDblFinder
    • Filtered separately for each sample

7 of 24

Doublet Detection

  • Doublets identified using scDblFinder (sample - wise detection)
  • Total cells after QC filtering : 112,196
  • Total cells after doublet removal: 106,298
  • Doublets removed: 5,898 cells
  • Final retention: 94.7% singlets

8 of 24

.

9 of 24

Normalization(SCTransform)

  • Normalized all 25 samples using SCTransform
  • Regressed mitochondrial percentage(percent.mt)
  • Removed technical noise and stabilized variance
  • Result: 106,298 high-quality cells ready for integration

10 of 24

Batch Correction(Harmony Integration)

  • Combined all 25 SCTransformed samples for integration
  • Performed PCA to capture major variance components
  • Selected 30 PCs based on the elbow plot
  • Applied Harmony to correct donor specific batch effects
  • Samples align well after correction while preserving true biology

Selected 30PCs

11 of 24

Before Integration (Batch Effects)

  • UMAP shows strong batch effects before integration
  • Samples cluster by donor, not biology
  • Technical variation dominates the structure, hiding true biology
  • Confirms the need for batch correction (Harmony)

12 of 24

After Integration(Harmony Corrected)

  • Harmony successfully removed donor-specific batch effects
  • Samples from all donors now overlap instead of forming separate clusters
  • Technical variation is greatly reduced
  • UMAP structure is cleaner and more biologically meaningful
  • Clustering becomes more stable after correction

13 of 24

Cluster Marker Identification (FindAllMarkers)

  • Identified top marker genes for each cluster using SCT-normalized data
  • Applied standard cutoffs: log2FC > 0.25 and min.25% expression
  • Extracted top 10 genes per cluster
  • Marker profiles used for biological interpretation
  • Basis for accurate cell-type annotation

14 of 24

Marker Gene Heatmap

15 of 24

Cluster Annotation(cell-type identification)

  • Identified top marker genes for each cluster
  • Compared marker profiles with established cell-type signatures
  • Assigned biological labels to clusters based on marker expression patterns
  • Added final labels to metadata and visualized on UMAP

Microglia clusters

16 of 24

Microglia Subsetting & Re-clustering

  • Extracted microglia by selecting clusters 20, 21 & 23 from the Harmony-integrated UMAP
  • Confirmed microglia identity using average expression of canonical markers
  • Subset contained 2,133 microglial cells
  • Re-processed microglia subset using:
    • Log Normalize
    • FindVariableFeatures
    • ScaleData
    • PCA
  • Re-clustered microglia subset

PC15 = Inflection point

17 of 24

Microglia Reclustering & Marker Based Cell Type Annotation

  • Re-clustered microglia subset using 15 PCs and resolution = 0.3
  • Identified top markers with FindAllMarkers
  • Annotated clusters using canonical marker genes
  • Final UMAP shows clear separation of microglial states

18 of 24

.

19 of 24

Differential Expression Analysis(MAST) on Microglia

  • Subsetted microglial states only (Homeostatic, Stress, Inflammatory, DAM-like MG)
  • Performed differential expression using MAST (single-cell hurdle model)
  • Two comparisons:
    • nAD vs NND
    • iAD vs nAD
  • Adjusted p-values using Benjamini–Hochberg (FDR < 0.05)
  • Extracted top up- and down-regulated genes for each comparison
  • Visualized significant genes using volcano plots (log2FC > 0.585, FDR < 0.05) to show up-regulated, down-regulated, and non-significant genes

20 of 24

Volcano Plot - nAD vs NND

21 of 24

Volcano plot - iAD vs nAD

22 of 24

GO Enrichment- nAD vs NND

.

23 of 24

GO Enrichment- iAD vs nAD

.

24 of 24

Conclusions

  • nAD microglia show significant metabolic stress and reduced neuroprotective function
  • iAD microglia show restored protective phenotype with decreased stress markers
  • Amyloid-β immunization shifts microglial state toward neuroprotection
  • Results suggest immunotherapy improves microglial health in Alzheimer's disease